Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J
Clin Pharmacol. 2016; 8:9-13. Epub 2016 Feb 11. PMID: 26929672.Abstract